These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 22804770)

  • 1. Carnitine Deficiency in Intensive Care Unit Patients Undergoing Continuous Renal Replacement Therapy.
    Fukami K; Taguchi K
    JMA J; 2024 Jan; 7(1):77-78. PubMed ID: 38314422
    [No Abstract]   [Full Text] [Related]  

  • 2. Chaihu-Guizhi-Ganjiang Decoction is more efficacious in treating irritable bowel syndrome than Dicetel according to metabolomics analysis.
    Li M; Zhu J; Liu X; Dong Z; Tang J; Zhang C; Jiao J; Chen J; Yin F; Qiu S; Zhang F; Gao S; Wang Z; Tao X; Yue X; Sun L; Chen W
    Chin Med; 2022 Dec; 17(1):139. PubMed ID: 36517857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder.
    Nie LJ; Liang J; Shan F; Wang BS; Mu YY; Zhou XH; Xia QR
    Front Psychiatry; 2021; 12():671151. PubMed ID: 34658942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Reducing L-Carnitine Supplementation on Carnitine Kinetics and Cardiac Function in Hemodialysis Patients: A Multicenter, Single-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Sugiyama M; Hazama T; Nakano K; Urae K; Moriyama T; Ariyoshi T; Kurokawa Y; Kodama G; Wada Y; Yano J; Otsubo Y; Iwatani R; Kinoshita Y; Kaida Y; Nasu M; Shibata R; Tashiro K; Fukami K
    Nutrients; 2021 May; 13(6):. PubMed ID: 34073024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease.
    Taguchi K; Fukami K; Elias BC; Brooks CR
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. l-carnitine supplementation vs cycle ergometer exercise for physical activity and muscle status in hemodialysis patients: A randomized clinical trial.
    Yano J; Kaida Y; Maeda T; Hashida R; Tonan T; Nagata S; Hazama T; Nakayama Y; Ito S; Kurokawa Y; Otome T; Shibata R; Tashiro K; Kakuma T; Matsuse H; Fukami K
    Ther Apher Dial; 2021 Jun; 25(3):304-313. PubMed ID: 32777142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-Carnitine Supplementation Improves Self-Rating Depression Scale Scores in Uremic Male Patients Undergoing Hemodialysis.
    Tashiro K; Kaida Y; Yamagishi SI; Tanaka H; Yokoro M; Yano J; Sakai K; Kurokawa Y; Taguchi K; Nakayama Y; Inokuchi T; Fukami K
    Lett Drug Des Discov; 2017 Jun; 14(6):737-742. PubMed ID: 28670223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients.
    Fukami K; Yamagishi S; Sakai K; Nasu M; Okuda S
    Clin Kidney J; 2014 Oct; 7(5):470-4. PubMed ID: 25878778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysis.
    Fukami K; Yamagishi S; Sakai K; Kaida Y; Adachi T; Ando R; Okuda S
    Rejuvenation Res; 2013 Dec; 16(6):460-6. PubMed ID: 23909402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products in renal failure: an overview.
    Noordzij MJ; Lefrandt JD; Smit AJ
    J Ren Care; 2008 Dec; 34(4):207-12. PubMed ID: 19090900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease.
    Smit AJ; Gerrits EG
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):527-33. PubMed ID: 20844429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients.
    Adachi T; Fukami K; Yamagishi S; Kaida Y; Ando R; Sakai K; Adachi H; Otsuka A; Ueda S; Sugi K; Okuda S
    Nephrology (Carlton); 2012 Nov; 17(8):689-94. PubMed ID: 22804770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?
    Arsov S; Graaff R; Morariu AM; van Oeveren W; Smit AJ; Busletic I; Trajcevska L; Selim G; Dzekova P; Stegmayr B; Sikole A; Rakhorst G
    Nephrol Dial Transplant; 2010 Mar; 25(3):885-91. PubMed ID: 19934094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients.
    Nagano M; Fukami K; Yamagishi S; Sakai K; Kaida Y; Matsumoto T; Hazama T; Tanaka M; Ueda S; Okuda S
    Nephrology (Carlton); 2011 Mar; 16(3):299-303. PubMed ID: 21054666
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.